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Aims Type II diabetes, often associated with abdominal obesity, frequently leads to heart failure.
Clinical and epidemiological evidence suggests that supplemental dyslipidaemia and hypertension, as clus-
tered in the metabolic syndrome, aggravate the cardiovascular outcome. The differential impact of type II
diabetes and the metabolic syndrome on left ventricular function, however, remains incompletely deﬁned.
Methods and results We studied left ventricular function in vivo using pressure–volume analysis in obese
diabetic mice with leptin deﬁciency (ob/ob) and obese diabetic dyslipidemic mice with combined leptin
and low-density lipoprotein-receptor deﬁciency (DKO). ob/ob and DKO mice developed a diabetic cardio-
myopathy,characterizedbyimpairedcontractilityandrelaxation,fromtheageof24 weeksonwards.This
was—at least partially—explained by increased apoptosis and disturbed Ca
2þ reuptake in the sarcoplasmic
reticulum (SR) in both mouse models. DKO, but not ob/ob, developed increased end-diastolic ventricular
stiffness, paralleled byincreased left ventricular myocardial ﬁbrosis. Cardiac outputwas preserved inob/
ob mice by favourable loading conditions, whereas it decreased in DKO mice.
Conclusions Type II diabetes in mice leads to impaired contractility and relaxation due to disturbed Ca
2þ
reuptake in the SR, but only when dyslipidaemia and hypertension are superimposed does vascular–
ventricular stiffening increase and left ventricular myocardial ﬁbrosis develop.
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1. Introduction
Patients with type II diabetes are at increased risk of devel-
oping heart failure.
1 The existence of a primary diabetic
cardiomyopathy characterized by diastolic and/or systolic
impairment was demonstrated before in type II diabetic
mouse models.
2,3 In type II diabetic patients abdominal
obesity, dyslipidaemia, and hypertension are known associ-
ated risk factors for the development of heart failure.
4
These ‘metabolic syndrome’ features promote athero-
sclerotic plaque formation and might additionally induce
ischaemic heart disease.
5 In patients with the metabolic
syndrome the relative contribution of the dyslipidemic/
atherosclerotic component and the diabetes/obesity com-
ponent in the development of heart failure is incompletely
known. In the current study, we investigated cardiac con-
tractility and haemodynamics in the single knockout leptin-
deﬁcient ob/ob mouse model for obesity and type II diabetes
and in a double knockout (DKO) mouse model with combined
deﬁciency of leptin and of the low-density lipoprotein
receptor (LDLR) presenting the metabolic syndrome exhibit-
ing type II diabetes, hypertension, obesity, dyslipidaemia,
and atherosclerosis.
6,7 The development of haemodynamic
alterations was studied at the age of 12, 24, and 36 weeks.
Increased cardiac myocyte apoptosis and depressed sarco-
plasmic reticulum (SR) Ca
2þ pump (SERCA2a) activity were
associated with cardiac dysfunction in the ob/ob mouse
model of type II diabetes and obesity.
8.9 Sustained dyslipi-
daemia is known to increase ceramide production, which
trough nitric oxide formation causes apoptosis. Further-
more, SERCA activity is critically dependent on the mem-
brane composition, which is in turn affected by the plasma
lipid composition.
10,11 We hypothesised that in subjects
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 with the metabolic syndrome apoptosis and SERCA2a, dys-
function would be exacerbated. Therefore, we assessed
the degree of apoptosis in the aforementioned single and
double KO models. The expression of SERCA2a, its regulatory
protein phospholamban (PLB), and its phosphorylation status
were measured as well as SERCA2a activity.
2. Methods
2.1 Experimental animals
Experiments were conducted in C57BL/6J (WT) (n ¼ 67), homozy-
gous LDL receptor knockout mice (LDLR
2/2)( n ¼ 60), ob/ob (n ¼
46), and DKO (n ¼ 51) mice at 12, 24, or 36 weeks of age, of
either sex. Mice were backcrossed for at least 10 generations into
the C57BL/6J background and mice had 98.4% C57BL/6J back-
ground. LDLR
2/2, heterozygous ob/þ, and C57BL/6J mice were
purchased from Jackson Laboratory (Bar Harbor, ME, USA). Homozy-
gous ob/ob and DKO mice were generated as described previously.
6
The investigation conforms with the Guide for the Care and Use of
Laboratory Animals published by the US National Institutes of Health
(NIH Publication No. 85-23, revised 1996).
2.2 Biochemical parameters
Blood of conscious mice was collected by tail bleeding into EDTA
tubes after a 24 h fast. Plasma was obtained by centrifugation.
Plasma insulin was determined with a mouse insulin ELISA (Merco-
dia), triglycerides and total cholesterol with a diagnostic reagent
kit (Roche), and glucose with a glucometer (Menarini Diagnostics).
Insulin resistance was calculated by a homeostasis model assess-
ment (HOMA-IR) ¼ fasting serum insulin (mU/L) times fasting
blood glucose (mM)/22.5. To determine glucose tolerance, glucose
was measured in samples obtained by tail bleeding before and 15,
30, 60, 120, 240, and 360 min after intraperitoneal glucose admin-
istration (20% glucose solution, 2 g/kg). The area under the curve
(AUC) was used as a measure of glucose tolerance.
2.3 In vivo haemodynamic measurements
2.3.1 Left-ventricular pressure–volume analysis
The metabolic syndrome is associated with hypertrophy and altera-
tions in pre- and afterload. This renders the conventional load-
dependent parameters unreliable as parameters of contractility.
12
Therefore, in vivo cardiac performance was measured by both load-
dependent and load-independent parameters derived from
pressure–volume loops, obtained in vivo using miniaturized
pressure-conductance catheterization, as previously described.
2
Brieﬂy, mice were anesthetized with a mixture of urethane
(1200 mg/kg)–a-chloralose (50 mg/kg) and were mechanically ven-
tilated. A pressure-conductance catheter (1.4-Fr, SPR-839; Millar
Instruments, Houston, TX, USA) was inserted in the left ventricle
(LV), via the carotid artery. After stabilization, steady-state
measurements were recorded. Heart rate (HR), end-diastolic
volume (Ved) as a parameter for preload, arterial elastance (Ea)a s
a parameter for afterload, the maximum and minimum rate of
pressure development (dP/dtmax,d P/dtmin), the time constant of
relaxation during isovolumetric diastole (t), and cardiac output
(CO) were derived. Load-independent parameters of contractility
[end-systolic elastance (Ees), preload-recruitable stroke work
(PRSW), and the slope of the end-diastolic pressure–volume
relationship (EDPVR)] were obtained by decreasing LV preload (tem-
porary occlusion of the inferior vena cava). EDPVR was calculated
using a linear ﬁt (EDPVR linear) and using an exponential ﬁt
(EDPVR exp). Ventriculo-arterial coupling was determined by the
relationship between Ees and Ea (Ees/Ea). Because small differences
in contractility are often indiscernible in basal conditions, cardiac
reserve was tested by catecholamine administration. Therefore,
stepwise increasing doses of dobutamine (0–10 mg/kg/min) were
administered by continuous infusion in the jugular vein, after
recording baseline haemodynamic parameters. Absolute volume
was calculated using the hypertonic saline and cuvette calibration
method.
2
2.3.2 Blood–pressure telemetry
In a subgroup of 24 week old mice, miniaturized telemetry devices
(Datascience Corp) were implanted as previously described
13 and
mice were left to recover for at least 1 week before recordings
were done. Pulse pressure (PP) and mean arterial blood pressure
(MABP) were measured, derived from blood pressure signals
sampled at 2000 Hz (Notocord HEM 3.4 software).
2.4 Analysis of SERCA2a expression and function
Oxalate-supported Ca
2þ uptake was measured in total cardiac hom-
ogenates under conditions that restricted Ca
2þ uptake to the SR.
14
The maximal velocity of Ca
2þ uptake (Vmax), the Ca
2þ concentration
required for half-maximal activation (Km), and the Hill coefﬁcient
(n) were calculated by non-linear regression analysis (Microcal
Origin software), based on the Hill equation:
n ¼
Vmax½Ca2þ 
n
Km þ½ Ca2þ 
n :
Ventricular homogenates were analysed by standard Western blot-
ting.
14 Phosphatase activity was inhibited with (nmol/L) 25 NaF, 5
Na-EDTA, 5 Na4P2O7, and a phosphatase inhibitor cocktail (Sigma,
P2850). Equal amounts of protein were separated on 4–20%
Bis-Tris gradient gels (NuPAGE, Invitrogen) and blotted onto PVDF
membranes (Immobilon-P, Millipore Corp.). Membranes were
probed with primary antibodies against SERCA2a,
15 PLB (A1 anti-
body, UBI), phosphoserine (PS16), and phosphothreonine (PT17) of
PLB (Cyclacel). Phosphorylation of PLB relieves the functional inhi-
bition of SERCA by PLB, thereby increasing the pump’s afﬁnity,
without changing the maximal pumping rate. Protein kinase A
(PKA) and Ca
2þ calmodulin kinase II (CaMKII) are the physiological
relevant kinases, which phosphorylate PLB. PKA is activated upon
b-adrenergic stimulation and phosphorylates PLB at the serine 16
site. CaMKII is activated in the presence of high Ca
2þ levels and/
or secondary to increased intracellular cAMP levels; it phosphory-
lates PLB at the threonine 17 site.
16 Detection was performed
using secondary antibodies coupled to alkaline phosphatase and
the ECF substrate (Amersham Pharmacia Biotech).
2.5 Histology
Hearts were perfused and injected with 100 mL saline containing
0.1 mM CdCl2. Afterwards, hearts were excised and embedded in
Tissue Freezing medium (Leica Microsystems) and frozen in liquid
N2. Oil Red O staining of cross-sections (7 mm) from the aortic
root and throughout the ventricle was used to quantify the extent
of the atherosclerotic lesions in the aortic arch, respectively, coron-
ary arteries. Sirius Red staining was used to visualize collagen. The
amount of collagen was quantiﬁed as percentage Sirius Red stained
area per total cardiac area.
17 A total of ﬁve images per animal were
analysed to evaluate cardiac ﬁbrosis. Haematoxylin/Eosin (H&E)
staining was used for routine histological examination. The
average cardiomyocyte cross-sectional area was evaluated in the
subendocardial layer, the central and the subepicardial layer of
the LV, on H&E-stained sections. Sixty cells were measured per
heart. To quantify the relative numbers of cells with DNA fragmen-
tation, TUNEL assay was performed in heart tissue sections using the
FragEL DNA Fargmentation Detection Kit (Calbiochem), according to
the protocol of the manufacturer. To determine the percentage
apoptotic cells, TUNEL-positive and TUNEL-negative cells were
counted. Results are expressed as number of TUNEL-positive
cells/total cells   100%. All morphometric analysis was performed
blinded with the Quantimet600 Image Analyzer (Leica).
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 2.6 Statistical analysis
All statistical analyses were performed using Statistica 6.0 (Statsoft,
Tulsa, OK, USA). Data are expressed as mean+SD, unless otherwise
speciﬁed. Differences between groups were compared by 1-way
ANOVA followed by a LSD post hoc test. Repeated measures were
compared by Repeated Measures ANOVA. Correlations were deter-
mined by the Pearson test. A value of P , 0.05 was considered
signiﬁcant.
3. Results
3.1 Biochemical analysis at 12, 24, and 36 weeks
Body weight was higher in ob/ob and DKO mice compared
with WT at all ages. Glucose and insulin levels, and thus
the HOMA-IR index were equally elevated in ob/ob and
DKO mice. Glucose tolerance was impaired in ob/ob and
DKO mice compared with that from WT. Total cholesterol
levels were elevated in LDLR
2/2 and DKO mice, compared
with WT and ob/ob. In LDLR
2/2 mice, total cholesterol
was approximately three times higher than in WT, whereas
in DKO mice total cholesterol reached even 10 times
higher levels. Plasma triglycerides were signiﬁcantly higher
in DKO mice in comparison with WT and ob/ob, at all ages.
In 36 weeks old LDLR
2/2 mice, triglyceride levels were
higher (Table 1).
3.2 In vivo cardiac performance
3.2.1 Left-ventricular pressure–volume analysis
No statistical differences were observed between WT
and LDLR
2/2 mice at any age, nor were there signiﬁcant
age-dependent haemodynamic changes in these mice (data
not shown). Representative examples of pressure volume
loops during preload reduction are shown in Figure 1.
Figure 2 summarizes the baseline in vivo data of the ob/
ob, DKO, and WT mice.
HR in ob/ob and DKO mice was slightly lower than in WTat
36 weeks of age. Left ventricular end-diastolic volume (Ved)
was similar in the different genotypes at 12 weeks of age;
thereafter, it decreased with age in DKO mice and increased
with age in ob/ob mice. At 36 weeks, Ved was signiﬁcantly
higher in ob/ob mice and lower in DKO mice in comparison
with WT. Arterial elastance (Ea) was lower in both ob/ob
and DKO mice at 12 weeks of age in comparison with WT.
Whereas it remained low in ob/ob mice, it increased with
age in DKO mice. From 24 weeks onwards, the difference
in Ea between DKO and WT disappeared. Ea is calculated
as the end-systolic pressure divided by the stroke volume.
It was mainly the differential change in stroke volume
(increased in ob/ob, but decreased in DKO in function of
age) leading to the observed differences in Ea (data not
shown). Contractility was impaired in both ob/ob and DKO
mice from 24 weeks onwards, which was evidenced by a
decrease of the load-independent PRSW. End-systolic ela-
stance (Ees) was also lower at 24 weeks in these mice.
However, in 36 weeks old DKO mice, Ees was not different
from WT. Load-dependent dP/dtmax and EF (data not
shown) were comparable in all groups at 24 and 36 weeks
of age. Whereas early diastolic relaxation (dP/dtmin, t)
was similarly impaired from age 24 weeks onwards in
both ob/ob and DKO mice, ventricular stiffness (EDPVR
linear and EDPVR exp) was only increased in DKO mice.
Table 1 Biochemical parameters in 12, 24, and 36 weeks old WT, ob/ob, and DKO mice
WT LDLR
2/2 ob/ob DKO
12 weeks n ¼ 16 n ¼ 14 n ¼ 10 n ¼ 8
Weight (g) 23.7+3.4 21.5+2.9 43.3+5.2* 46.6+4.3*
Glucose (mM) 4.3+1.8 4.3+1.8 9.6+3.2* 9.9+1.3*
Total cholesterol (mg/dL) 63+10 183+46* 109+35 604+103*,**
Triglycerides (mg/dL) 58+13 78+17 61+10 499+238*,**
Insulin (mU/L) 384+269 468+164 1263+494* 1384+534*
HOMA-IR 73+21 108+21 539+70* 609+79*
AUC of the IPGTT ( 10
4) 5.7+0.88 5.6+2.3 11.6+3.4* 12.3+5.5*
24 weeks n ¼ 14 n ¼ 14 n ¼ 8 n ¼ 14
Weight (g) 26.5+4.7 26.8+3.0 59.7+4.5* 57.3+3.6*
Glucose (mM) 4.3+0.83 4.6+0.49 9.2+5.3* 9.6+2.0*
Total cholesterol (mg/dL) 78+19 213+68* 136+51 584+170*,**
Triglycerides (mg/dL) 43+56 5 +20 49+13 458+178*,**
Insulin (mU/L) 330+100 310+78 1849+580* 1504+489*
HOMA-IR 63+46 4 +7 756+136* 642+139*
AUC of the IPGTT ( 10
4) 6.2+1.1 6.9+2.3 13.3+4.4* 15.2+3.0*
36 weeks n ¼ 19 n ¼ 14 n ¼ 10 n ¼ 11
Weight (g) 28.8+3.8 27.4+4.1 68.9+10.5* 58.7+6.7*
Glucose (mM) 3.9+0.85 4.2+0.6 8.9+5.0* 9.0+4.2*
Total cholesterol (mg/dL) 57+13 269+110* 94+23 422+154*
,**
Triglycerides (mg/dL) 49+11 114+17* 52+13 497+368*
,**
Insulin (mU/L) 366+149 364+289 1613+523* 1402+640*
HOMA-IR 63+5 67.5+8.0 638+116* 561+119*
AUC of the IPGTT ( 10
4) 5.6+1.9 5.8+1.7 8.0+3.4 9.2+3.8*
HOMA-IR indicates homeostasis model assessment; AUC, area under the curve; IPGTT, intraperitoneal glucose tolerance test.
*P , 0.05 vs. WT.
**P , 0.05 vs. ob/ob.
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 Ventriculo-arterial stiffening (Ea/Ees) was higher in DKO
mice in comparison with ob/ob and WT at an age of 24
weeks. At 36 weeks, there were no signiﬁcant differences
anymore. CO was signiﬁcantly higher in ob/ob and DKO
mice at 12 weeks of age. Whereas CO decreased in DKO
mice with age, it increased in ob/ob mice.
Figure 2 Baseline haemodynamic parameters. (A) Heart rate (HR), (B) end-diastolic volume (Ved), (C) arterial elastance (Ea), (D)d P/dtmax,( E)
preload-recruitable stroke work (PRSW), (F) end-systolic elastance (Ees), (G)d P/dtmin,( H) t,( I) ratio Ea/Ees,( J) end-diastolic pressure volume relationship
ﬁtted linearly (EDPVR linear), (K) end-diastolic pressure volume relationship ﬁtted exponentially (EDPVR exp), and (L) cardiac output (CO) in WT (ﬁlled
square), ob/ob (ﬁlled circle), and DKO (ﬁlled triangle) mice of 12, 24, and 36 weeks of age. Data are mean+SEM. *P , 0.05 vs. WT,
†P , 0.05 vs. ob/ob.
Figure 1 Representative examples of left ventricular pressure–volume loops during caval occlusion. Dotted lines represent the end-systolic pressure–volume
relationship with slope Ees (index for systolic contractility and stiffness); dashed lines represent the end-diastolic pressure–volume relationship (EDPVR linear),
the slope of which is an index of diastolic stiffness. The ob/ob mouse is characterized by large stroke volumes and large Ved and a depression of the Ees. In DKO
mice, a leftward shift and steep slope of the end-systolic pressure–volume relationship and small stroke volumes and low Ved are observed. Also the slope EDPVR
was steeper in these mice.
A. Van den Bergh et al. 374
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 Cardiac reserve was measured during administration of
stepwise incremental doses of dobutamine (Figure 3). Two
DKO mice died at a dose of 3 mg/kg/min. These animals
were excluded for the repeated measures analysis. A posi-
tive chronotropic (HR), inotropic (PRSW), and lusitropic
(dP/dtmin) response was observed in WT mice upon
b-stimulation. Inotropic and lusitropic parameters increased
less in ob/ob and DKO mice than in WT, however with a
normal chronotropic response. Interestingly, whereas both
ob/ob and DKO mice showed a severely impaired cardiac
reserve, only in DKO mice PRSW and CO did not increase
further at the highest doses, even tended to decrease.
3.2.2 Blood-pressure telemetry
PP was signiﬁcantly higher in ob/ob and DKO mice
(33.5+ 1.4, respectively. 32.2+1.0 mmHg) when com-
pared to WT (24.9+0.9 mmHg) and LDLR
2/2 mice
(24.9+1.2 mmHg). MABP was 101.8+1.1 mmHg in WT,
and was signiﬁcantly higher in LDLR
2/2 (111+1.2 mmHg),
ob/ob (108.7+1.8 mmHg), and DKO mice (111.4+
1.2 mmHg).
3.3 SERCA2a expression and activity
The averaged curves of Ca
2þ reuptake in fragmented SR
from 36 weeks old animals are presented in Figure 4A.
Representative examples of western blots of ventricular
SERCA2a, PLB, PS16, and PT17 in WT, ob/ob, and DKO
mice at 12 and 36 weeks are given in Figure 4B and C.
Figure 4D–G summarizes the results after analysis. No stat-
istical differences were observed between WT and LDLR 2
/2 mice (data not shown).
At 12 weeks of age, increased SERCA2a levels but
unchanged expression of PLB were observed in ob/ob and
DKO mice. PLB serine 16 was relatively less phosphorylated,
indicating a stronger inhibition of the Ca
2þ pump. The com-
bination of these factors resulted in a comparable SR Ca
2þ
reuptake in both ob/ob and DKO mice vs. WT (Table 2). At
older ages, the PLB/SERCA2a ratio is normalized. The frac-
tion of PLB phosphorylated on serine 16 remained lower
but the fraction phosphorylated on threonine 17 increased
signiﬁcantly with age in both ob/ob and DKO mice.
However, this increase could not overcome the effect of a
lower PLB phosphorylation level on Serine 16, since Ca
2þ
reuptake experiments revealed a signiﬁcantly lower appar-
ent Ca
2þ afﬁnity of SERCA2a (i.e. a higher Km value) in
ob/ob and DKO mice at 24 and 36 weeks of age (Table 2).
The Hill coefﬁcient was lower in DKO mice compared to
WT at 36 weeks of age (Table 2).
3.4 Histology
As shown in Figure 5A, heart weight was signiﬁcantly higher
in ob/ob mice than in WT at 12, 24, and 36 weeks of age,
with heart weight in DKO taking intermediary positions.
Myocyte diameters of both ob/ob and DKO mice were signiﬁ-
cantly larger in comparison with WT (Figure 5B).
ob/ob and DKO mice showed markedly elevated apoptosis
in comparison with WT mice (Figure 5C). At an age of 36
weeks, the level of apoptosis in DKO mice exceeded that
in ob/ob mice.
Whereas the area of the red-staining collagen was com-
parable in WT and ob/ob mice at all ages studied, it
increased with age in DKO mice (Figure 5D). From an age
Figure 3 Cardiac performance during beta-adrenergic stimulation in 24 weeks old mice. Incremental doses of dobutamine (D0–D10 mg/kg/min) were adminis-
tered by continuous infusion to test cardiac reserve during stress. Dose-response curve for (A) heart rate (HR), (B) preload-recruitable stroke work (PRSW), (C)
dP/dtmin, and (D) cardiac output (CO) in WT (ﬁlled square), ob/ob (ﬁlled circle), and DKO (ﬁlled triangle) mice. Whereas the chronotropic response was normal,
ob/ob and DKO mice displayed an impaired inotropic and lusitropic response during dobutamine-infusion, as outlined by, respectively, PRSW and dP/dtmin. Data
are mean+SEM. *P , 0.05 vs. WT,
†P , 0.05 vs. ob/ob.
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 of 24 weeks onwards, collagen content was signiﬁcantly
higher in DKO mice, compared with the WT and ob/ob.
No atherosclerotic lesions were detected in the aorta of
C57BL6/J and ob/ob mice at any age, and in LDLR
2/2
mice they were only very small (even at 36 weeks of age)
(always less than 0.01 mm
3). Figure 5E shows representative
oil red O-stained cross-sections of the aortic root of DKO
mice at 12, 24, and 36 weeks. In 12 weeks old DKO mice,
lesions were small fatty streaks. Plaque volumes increased
from 0.008+0.004 mm
3 at 12 weeks to 0.081+0.049 mm
3
at 24 weeks and 0.156+0.020 mm
3 at 36 weeks. Athero-
sclerotic plaque volume in the aortic arch of DKO
mice was positively correlated with arterial elastance, a
parameter for afterload (R ¼ 0.69; P , 0.05) (Figure 5F).
No atherosclerotic lesions were found in epicardial and
intramyocardial coronary arteries.
4. Discussion
This work provides evidence that left ventricular relaxation
and contractility when assessed with load-independent
parameters are impaired in mice with abdominal obesity
and type II diabetes. SERCA2a activity paralleled the
in vivo ﬁndings of relaxation and contractility. Ventricular-
vascular stiffening and signs of deterioration of the cardiac
reserve after b-adrenergic stimulation were only observed
Figure 4 Analysis of the SR Ca
2þ reuptake. (A) Oxalate supported Ca
2þ uptake measurements in 36 weeks old WT (ﬁlled square), ob/ob (ﬁlled circle), and DKO
(ﬁlled triangle) mice. Ca
2þ uptake rates are normalized to the maximal uptake rate of the group. (B and C) Representative examples of western blots of total
ventricular homogenates. Blots were probed with antibodies to SERCA2a, PLB, PLB phosphorylated on Serine 16 (PS16) and PLB phosphorylated on Threonine 17
(PT17) in mice of 12 (B) and 36 (C) weeks of age. (D–G) The graphs show the relative expression levels obtained by western blots. Experiments were performed in
triplicate (n ¼ 6 for each group). Data are presented as mean+SEM. * P , 0.05 vs. WT.
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 when atherogenic dyslipidaemia was superimposed on an
obesity/diabetes background. This was accompanied by
increasing left ventricular ﬁbrosis. These results offer new
insights into the role of dyslipidaemia in the pathogenesis
of diabetes/obesity-associated cardiovascular disease.
4.1 Atherogenic dyslipidaemia superimposed
on obesity and type II diabetes does not
further aggravate systolic and early
diastolic dysfunction in mice
Reduced PRSW indicates impaired contractility in ob/ob
and DKO mice. The steepness of the end-systolic pressure–
volume relationship (Ees) in DKO mice is not due to improved
myocardial function but instead to small chamber volumes
(Ved) and hypertrophy.
18 Also the unchanged values of
dP/dtmax and ejection fraction in DKO mice vs. controls in
the presence of concentric hypertrophy indicate a sub-
stantial dysfunction, since the subnormal shortening of
extra parallel sarcomeres may overestimate these para-
meters.
19,20 In ob/ob mice, the preserved dP/dtmax and EF
are attributable to, respectively, a high preload and a low
afterload.
Contractility (PRSW) and early relaxation (dP/dtmin)
decreased in a comparable way in ob/ob and DKO mice
from an age of 24 weeks onwards. In other words, the dysli-
pidaemia superimposed on obesity and insulin resistance,
characterizing the DKO mouse model, does not alter in
vivo contractility and relaxation. Besides the possible invol-
vement of other essential parameters of the contractile
protein apparatus responsible for impaired function, we
focused on the contribution of cardiac myocyte apoptosis
and SR Ca
2þ reuptake capacity in these mice. Cardiac
myocyte apoptosis, even at low levels, is well recognized
as an important step in the development of heart failure.
Because increased apoptosis was already evident at an age
of 12 weeks in both ob/ob and DKO mice, our ﬁndings
suggest that this might trigger cardiac dysfunction. The SR
Ca
2þ reuptake activity paralleled the in vivo functional
measurements. Indeed, SERCA2a afﬁnity for Ca
2þ was
reduced to the same extent at all ages in ob/ob and DKO
mice, indicating that also for this aspect, dyslipidaemia
does not have an additional impact. On the other hand,
the Hill coefﬁcient was lower in the DKO mice, suggesting
a possible role for dyslipidaemia in the cooperativity
between Ca
2þ ions and the SERCA2a molecule. However,
the alterations in Hill-coefﬁcient apparently do not have
major inﬂuences on in vivo cardiac contractile performance
in DKO mice. Thus, despite this possible interaction, dyslipi-
daemia does not seem to have an important role in the
Table 2 Oxalate-supported Ca
2þ reuptake measurements in 12,
24, and 36 weeks old WT, ob/ob, and DKO mice
WT ob/ob DKO
12 weeks
Vmax 45.1+24.0 56.7+25.2 53.8+16.2
Km 0.34+0.10 0.37+0.08 0.38+0.12
Hill 2.03+0.49 1.83+0.57 1.86+0.90
24 weeks
Vmax 45.3+12.2 50.2+13.2 47.7+17.5
Km 0.33+0.04 0.39+0.06* 0.39+0.03*
Hill 2.24+0.44 1.97+0.26 1.96+0.18
36 weeks
Vmax 36.5+4.8 43.4+17.3 41.9+10.8
Km 0.31+0.03 0.37+0.10* 0.39+0.09*
Hill 2.1+0.19 1.95+0.61 1.67+0.37*
Maximal Ca
2þ uptake rate in nmol Ca
2þ/mg protein/min (Vmax), appar-
ent Ca
2þ afﬁnity in mM( Km), and the Hill coefﬁcient are summarized for
WT, ob/ob, and DKO mice of 12, 24, and 36 weeks of age. Experiments
were performed in triplicate (n ¼ 6 for each group).
*P , 0.05 vs. WT.
Figure 5 Histology. (A) Heart weight, (B) myocyte diameters, (C) levels of apoptosis, and (D) collagen accumulation in 12, 24, and 36 weeks old WT (ﬁlled
square), ob/ob (ﬁlled circle), and DKO (ﬁlled triangle) mice. Data are presented as mean+SEM (n ¼ 5 for each group). *P , 0.05 vs. WT,
†P , 0.05 vs. ob/ob.
(E) Representative cross-sections of aortic arch from DKO mice at 12, 24, and 36 weeks. (F) Correlation of plaque volume with arterial elastance (Ea), as parameter
for afterload.
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 development of contractile dysfunction related to impaired
SR function in type II DM.
Our study revealed that the reduced SERCA2a activity
observed in 24 and 36 weeks old ob/ob and DKO mice
results mainly from altered regulation and phosphorylation
state of PLB. A signiﬁcantly decreased Serine 16 phosphoryl-
ation level was detected at all ages, whereas the phos-
phorylation level on Threonine 17 was normal at 12 weeks
but afterwards increased with age. At baseline conditions,
Serine 16 phosphorylation is thought to play a more domi-
nant role in controlling SERCA2 activity than on Threonine
17.
21 It remains to be elucidated which components of the
phosphorylation pathways are defective in ob/ob and DKO
mice. Impaired PKA activity was postulated to result from
leptin deﬁciency, leading to decreased Serine 16 phosphoryl-
ation.
22 Increased CaMKII activity results from increased
cytosolic Ca
2þ concentrations and may lead to increased
Threonine 17 phosphorylation.
21 Although no study to date
was performed regarding intracellular Ca
2þ levels in ob/ob
or DKO mice, we demonstrated in both mouse models the
development of cardiac hypertrophy. Interestingly, numer-
ous studies indicate that cardiac hypertrophy is associated
with elevated intracellular Ca
2þ.
23,24 Besides altered PKA
and CaMKII activity, the role of phosphatases in controlling
the phosphorylation status of PLB may not be underesti-
mated. Recently, it was shown that phosphatases might
play a crucial role in hypertrophic cardiomyopathy.
25,26
4.2 Atherogenic dyslipidaemia superimposed on
obesity and type II diabetes increases ventricular
stiffness in leptin-deﬁcient mice
The most important difference in the haemodynamic proﬁle
between ob/ob and DKO mice lies in the parameters deﬁning
stiffness/compliance. The three parameters deﬁning stiff-
ness using pressure–volume relationships are the end-
systolic elastance (Ees), the arterial elastance (Ea), and the
slope of the EDPVR. It was previously reported that ventricu-
lar systolic and diastolic stiffening increase in tandem with
artery stiffening, which is likely linked to the coupling of
the heart and the vascular system.
27 Indeed, the DKO
mouse displays marked increases in both end-systolic and
arterial elastance in comparison to ob/ob mice. The dias-
tolic pressure–volume relation is also steeper in the DKO
mice. We already remarked that the steepness of the Ees
in DKO mice does not reﬂect improved myocardial function
but instead is related to the small chamber volumes (Ved)
and hypertrophy.
18 The increase in Ea in DKO mice in
function of age might, at least partially, be related to
atherosclerotic plaque formation. We observed, in this
study, a positive correlation between atherosclerotic plaque
volume and arterial elastance in DKO mice. In ob/ob mice,
Ea was lower compared to WT at all ages. Ea is linearly
related to both total peripheral resistance (R) and the reci-
procal of the compliance (1/C).
28 The low Ea in ob/ob mice
seems to be in agreement with studies in massively obese
patients without signs of hypertension exhibiting reduced
peripheral resistance and normal arterial compliance.
29
When massive obesity is combined with atherosclerosis,
the net result on arterial elastance is more difﬁcult to
predict. It is tempting to speculate that the atherosclerotic
lesions in these mice might decrease aortic compliance to
such an extent, that it counteracts the reduced Ea observed
in ob/ob mice. However, whereas plaque volume doubled
from age 24 to 36 weeks, there was only a modest (10%)
increase in Ea. This is in agreement with the ﬁndings of
Segers et al.,
28 who reported that the sensitivity of Ea to
1/C is three times lower than to R. Hence, the compliance
term only contributes for a minor part to changes in Ea.
The telemetric measurements are in line with these ﬁnd-
ings. In both ob/ob and DKO mice, a higher PP was observed.
PP arises from the interaction of cardiac ejection (stroke
volume) and the properties of the arterial circulation.
30 A
higher PP in ob/ob mice might be attributed to a higher
stroke volume; but in DKO mice, stroke volume is normal,
thus the higher PP is likely to be generated by an increased
stiffness of the major arteries, in line with the increased Ea.
Finally, the steepness of the EDPVR in DKO mice could be
related to the increase in intramyocardial collagen accumu-
lation (Figure 5C). No deposition of collagen, with concomi-
tant increased passive stiffness was detected in ob/ob mice.
The age-related rise in Ea in the DKO mice was associated
with a modest rise in ventricular Ees, meaning that simul-
taneous ventricular-vascular stiffening maintained an equal
Ea/Ees ratio. In comparison with the ob/ob mice, both
parameters were signiﬁcantly elevated from an age of
24 weeks. One could anticipate that it would be beneﬁcial
when the Ea/Ees ratio is maintained; however, important
consequences may arise in the cardiac response to increased
ﬁlling volumes, since a stiff heart-arterial system generates
more systolic pressure change for a given change in ventricu-
lar volume. A higher pressure will be generated, but a
smaller ejected stroke volume will be achieved. This
means that although both Ees and Ea/Ees ratio are normal
in DKO mice, the way the heart responds to preload altera-
tion is changed.
Interestingly, Hundley et al.
31 reported that such ‘coupled
stiffening’ contributes to stress intolerance, a ﬁnding which
is conﬁrmed by our study. DKO mice displayed a worse con-
tractile reserve upon dobutamine-stimulation in comparison
with ob/ob mice.
5. Conclusion
The pattern of left ventricular dysfunction development in
the leptin-deﬁcient ob/ob mouse—as a model of type II dia-
betes—and in the DKO (LDLR
2/2;ob/ob) mouse—as a model
featuring several characteristics of the metabolic syndrome
(including obesity, type II diabetes, hyperlipidaemia, and
atherosclerosis)—can clearly be differentiated. Left ventri-
cular contractility and early diastolic relaxation are
impaired in both obese diabetic mouse models, and are
related to increased apoptosis and defective SR Ca
2þ
reuptake. The additional features of the metabolic syn-
drome (apart from obesity and insulin resistance) seem to
be responsible for a differential pattern of remodelling,
for an increased passive ventricular stiffness, and intramyo-
cardial ﬁbrosis. Arterial elastance is lower in obese diabetic
mice, but this is counteracted by the atherosclerotic dyslipi-
daemia at 24 and 36 weeks, in parallel with the develop-
ment of atherosclerotic lesions. The global cardiac
phenotypic outcome in the DKO mice model of the meta-
bolic syndrome is worse than in the ob/ob mouse model of
type II diabetes.
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